lakeland semaglutide Weight-loss drug Wegovy available in Canada starting May 6 for people with obesity The 2026 Brandon GLP-1 Report:

Discontinuation rates due to adverse effects were also higher with retatrutide being 16-17% compared with 2% with dulaglutide and 0-4% with placebo

Injectables may remain preferred for patients needing maximum weight reduction

Final dosing will be determined after FDA approval and should only be followed under medical supervision

You also dont need to enroll in a retatrutide clinical trial if you are seeking more modest weight loss to optimize your health

After the official market entry of "Semaglutide for weight loss " (Novo Nordisk's Wegovy) in November, another important member of the semaglutide familyoral semaglutide , Rybelsusis set to take center stage in clinical practice